Integrated Filing — IndAS



General information about company

Scrip Code 544679
NSE Symbol AMAGI
MSEI Symbol NOTLISTED
ISIN INE121R01077
Name of company AMAGI MEDIA LABS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 20-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Single segment
Start date and time of board meeting 20-05-2026   07:45:00
End date and time of board meeting 20-05-2026   09:35:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 20-05-2026
Indicate Company website link for updated RPT policy of the Company https://www.amagi.com/hubfs/Policy%20on%20RPT%20and%20Material%20subsidiary_v2.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Amagi Media Labs Limited has not taken any loan or issued any debt securities. Hence, the disclosure is not applicable for the reporting period.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 24,889.60 94,923.20
Other income 2,416.00 6,453.10
Total income 27,305.60 1,01,376.30
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 8,480.80 36,403.50
(e) Finance costs 65.60 306.90
(f) Depreciation, depletion and amortisation expense 372.60 1,454.00
(f) Other Expenses
1 Rent 19.90 212.20
2 Legal professional charges and Recruitment charges 98.20 2,025.50
3 Marketing and sales promotion 114.70 414.30
4 Rates and taxes 206.90 281.00
5 Travel and conveyance 142.90 1,012.20
6 Communication costs 13,004.90 45,693.30
7 Membership, subscription 928.60 3,723.80
8 Repairs and maintenance and Power and fuel 151.10 482.50
9 Sales support services 1,511.20 5,306.60
10 Other Expenses 238.50 1,415.80
Total other expenses 16,416.90 60,567.20
Total expenses 25,335.90 98,731.60
3 Total profit before exceptional items and tax 1,969.70 2,644.70
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,969.70 2,644.70
6 Tax expense
7 Current tax 0.00 0.00
8 Deferred tax 0.00 0.00
9 Total tax expenses 0.00 0.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,969.70 2,644.70
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,969.70 2,644.70
17 Other comprehensive income net of taxes 180.20 72.10
18 Total Comprehensive Income for the period 2,149.90 2,716.80
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 10,817.00 10,817.00
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,52,231.60
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.89 1.27
Diluted earnings (loss) per share from continuing operations 0.88 1.26
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.89 1.27
Diluted earnings (loss) per share from continuing and discontinued operations 0.88 1.26
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to Audited Standalone Financial Results for the quarter and year ended March 31, 2026 1. The Audited Standalone Financial Results of Amagi Media Labs Limited (formerly Amagi Media Labs Private Limited (the Company) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013, as amended, read with the Companies (Indian Accounting Standards Rules), 2015, as amended and other accounting principles generally accepted in India and in terms of Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ('SEBI LODR'), as amended (Listing Regulations). These Standalone Financial Results have been reviewed by the Audit Committee at its meeting held on May 19, 2026 and approved by the Board of Directors at its meeting held on May 20, 2026. 2. The figures for the quarter ended March 31, 2026 and corresponding quarter ended March 31, 2025 are the derived balancing figure between audited figures in respect of the full financial year ended March 31, 2026 and March 31, 2025, respectively, and the unaudited figures of the nine months period ended December 31, 2025 and December 31, 2024, respectively. The unaudited figures for the nine months period ended December 31, 2025, as referred above, are an aggregate of the six months period ended September 30, 2025 which have been subjected to audit and the quarter ended December 31, 2025 which have been subject to limited review by the statutory auditors. The unaudited figures for the nine months period ended December 31, 2024, as referred above, have been compiled by the management and approved by the Board of Directors of the Company, which have not been subjected to audit or limited review by the statutory auditors. 3. During the quarter and year ended March 31, 2026, the Company has completed its Initial Public Offering (IPO) of 49,546,221 equity shares of nominal value of Rs. 5 each at an issue price of Rs. 361 per share (including securities premium of Rs. 356 per share). The issue comprised of a fresh issue of 22,603,878 equity shares aggregating to Rs. 8,160.00 million and an offer for sale of 26,942,343 equity shares by selling shareholders aggregating to Rs. 9,726.19 million. The Company's equity shares were listed on BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) on January 21, 2026. 4. During the year ended March 31, 2026, the Company, pursuant to a circular resolution dated July 15, 2025, converted 3,804 Series D1 Compulsorily Convertible Preference Shares of nominal value Rs. 100 each into equity shares of nominal value Rs. 5 each, in the conversion ratio of 1:72, in accordance with the terms of issue. The equity shares so issued rank pari passu with the existing equity shares of the Company. Further, on November 21, 2025 the Board of Directors of the Company approved conversion of 12,430,901 (all outstanding) Compulsorily Convertible Preference Shares into 159,300,958 Equity Shares of the Company. 5. During the year ended March 31, 2025, on October 9, 2024 the Company issued bonus shares aggregating to 33,211,325 in accordance with Section 63 of the Companies Act, 2013 in the ratio of 1:35 (for every 1 equity share 35 bonus shares were issued) to all equity shareholders with equity shares having nominal value of Rs. 5 each. The conversion ratio for convertible preference shares was changed for the effect of bonus issue. 6. The Board of Directors of Argoid Analytics Private Limited, a subsidiary, at its meeting held on November 17, 2025 has approved the liquidation of this subsidiary. 7. On November 21, 2025, the Government of India notified the Code on Wages, 2019, the Code on Social Security, 2020, the Industrial Relations Code, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the “Labour Codes”). The Labour Codes consolidate various existing labour laws and introduce changes, including a harmonised definition of wages, which impacts the computation of employee benefit obligations such as gratuity and compensated absences. Based on the information currently available and the guidance issued by the Institute of Chartered Accountants of India, the Company has evaluated the impact of these changes and recognised an incremental cost of Rs. 76.24 million as past service cost under employee benefits expense for the year ended March 31, 2026. The Company continues to monitor developments relating to the Labour Codes and will assess the impact, if any, on the measurement of employee benefit liabilities in future periods. 8. The Company has significant unabsorbed depreciation and carried forward losses and has also incurred tax losses for the year ended March 31, 2026. In view of the lack of reasonable certainty that sufficient taxable profits will be available with the Company in the foreseeable future against which such deferred tax assets can be realised, no deferred tax assets have been recognised by the Company in its standalone financial results as at March 31, 2026, in accordance with Ind AS 12. 9. The Company is engaged in the business of providing media technologies and related services which represents single reportable segment as per Ind AS 108, and hence no separate disclosures are required for segments.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 3,715.80
Capital work-in-progress
Investment property
Goodwill 0.00
Other intangible assets 520.90
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 4,600.20
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Security deposits 219.80
Total of other non-current financial assets 219.80
Total non-current financial assets 4,820.00
Deferred tax assets (net)
Other non-current assets
1 Income tax assets (net) 808.80
2 Prepaid expenses 16.40
Total of other non-current assets 825.20
Total non-current assets 9,881.90
2 Current assets
Inventories 0.00
Current financial asset
Current investments 22,937.70
Trade receivables, current 20,313.00
Cash and cash equivalents 16,376.20
Bank balance other than cash and cash equivalents 93,529.10
Loans, current 8.50
Other current financial assets
Total of other current financial assets 22,831.90
Total current financial assets 1,75,996.40
Current tax assets (net)
Other current assets
1 Advances to suppliers 37.80
2 Balances with statutory / government authorities 6,914.90
3 Prepaid expenses 1,353.10
Total of other current assets 8,305.80
Total current assets 1,84,302.20
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,94,184.10
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 10,817.00
Other equity 1,52,231.60
Total equity attributable to owners of parent 1,63,048.60
Non controlling interest
Total equity 1,63,048.60
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 1,462.80
Total of other non-current financial liabilities 1,462.80
Total non-current financial liabilities 1,462.80
Provisions, non-current 1,895.10
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 3,357.90
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 346.10
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 17,256.20
Total Trade payable 17,602.30
Other current financial liabilities
1 Lease liabilities 451.00
2 Payable to employees 3,471.10
3 Deposit from customers 111.10
4 Capital creditors 61.90
5 Other payables to related parties 294.90
Total of other current financial liabilities 4,390.00
Total current financial liabilities 21,992.30
Other current liabilities 4,223.50
1 Contract liabilities 1,079.90
2 Statutory dues payable 2,783.20
3 Other liabilities 360.40
Total of other current liabilities 4,223.50
Provisions, current 1,561.80
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 27,777.60
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 31,135.50
Total equity and liabilites 1,94,184.10
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Notes to Audited Standalone Financial Results for the quarter and year ended March 31, 2026 1. The Audited Standalone Financial Results of Amagi Media Labs Limited (formerly Amagi Media Labs Private Limited (the Company) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013, as amended, read with the Companies (Indian Accounting Standards Rules), 2015, as amended and other accounting principles generally accepted in India and in terms of Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ('SEBI LODR'), as amended (Listing Regulations). These Standalone Financial Results have been reviewed by the Audit Committee at its meeting held on May 19, 2026 and approved by the Board of Directors at its meeting held on May 20, 2026. 2. The figures for the quarter ended March 31, 2026 and corresponding quarter ended March 31, 2025 are the derived balancing figure between audited figures in respect of the full financial year ended March 31, 2026 and March 31, 2025, respectively, and the unaudited figures of the nine months period ended December 31, 2025 and December 31, 2024, respectively. The unaudited figures for the nine months period ended December 31, 2025, as referred above, are an aggregate of the six months period ended September 30, 2025 which have been subjected to audit and the quarter ended December 31, 2025 which have been subject to limited review by the statutory auditors. The unaudited figures for the nine months period ended December 31, 2024, as referred above, have been compiled by the management and approved by the Board of Directors of the Company, which have not been subjected to audit or limited review by the statutory auditors. 3. During the quarter and year ended March 31, 2026, the Company has completed its Initial Public Offering (IPO) of 49,546,221 equity shares of nominal value of Rs. 5 each at an issue price of Rs. 361 per share (including securities premium of Rs. 356 per share). The issue comprised of a fresh issue of 22,603,878 equity shares aggregating to Rs. 8,160.00 million and an offer for sale of 26,942,343 equity shares by selling shareholders aggregating to Rs. 9,726.19 million. The Company's equity shares were listed on BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) on January 21, 2026. 4. During the year ended March 31, 2026, the Company, pursuant to a circular resolution dated July 15, 2025, converted 3,804 Series D1 Compulsorily Convertible Preference Shares of nominal value Rs. 100 each into equity shares of nominal value Rs. 5 each, in the conversion ratio of 1:72, in accordance with the terms of issue. The equity shares so issued rank pari passu with the existing equity shares of the Company. Further, on November 21, 2025 the Board of Directors of the Company approved conversion of 12,430,901 (all outstanding) Compulsorily Convertible Preference Shares into 159,300,958 Equity Shares of the Company. 5. During the year ended March 31, 2025, on October 9, 2024 the Company issued bonus shares aggregating to 33,211,325 in accordance with Section 63 of the Companies Act, 2013 in the ratio of 1:35 (for every 1 equity share 35 bonus shares were issued) to all equity shareholders with equity shares having nominal value of Rs. 5 each. The conversion ratio for convertible preference shares was changed for the effect of bonus issue. 6. The Board of Directors of Argoid Analytics Private Limited, a subsidiary, at its meeting held on November 17, 2025 has approved the liquidation of this subsidiary. 7. On November 21, 2025, the Government of India notified the Code on Wages, 2019, the Code on Social Security, 2020, the Industrial Relations Code, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the “Labour Codes”). The Labour Codes consolidate various existing labour laws and introduce changes, including a harmonised definition of wages, which impacts the computation of employee benefit obligations such as gratuity and compensated absences. Based on the information currently available and the guidance issued by the Institute of Chartered Accountants of India, the Company has evaluated the impact of these changes and recognised an incremental cost of Rs. 76.24 million as past service cost under employee benefits expense for the year ended March 31, 2026. The Company continues to monitor developments relating to the Labour Codes and will assess the impact, if any, on the measurement of employee benefit liabilities in future periods. 8. The Company has significant unabsorbed depreciation and carried forward losses and has also incurred tax losses for the year ended March 31, 2026. In view of the lack of reasonable certainty that sufficient taxable profits will be available with the Company in the foreseeable future against which such deferred tax assets can be realised, no deferred tax assets have been recognised by the Company in its standalone financial results as at March 31, 2026, in accordance with Ind AS 12. 9. The Company is engaged in the business of providing media technologies and related services which represents single reportable segment as per Ind AS 108, and hence no separate disclosures are required for segments.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement (losses)/gains on defined benefit plans 180.20 72.10
Total Amount of items that will not be reclassified to profit and loss 180.20 72.10
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 180.20 72.10



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,644.70
Adjustments for reconcile profit (loss)
Adjustments for finance costs 288.50
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current (6,644.60)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,230.00)
Adjustments for decrease (increase) in other non-current assets 15.30
Adjustments for other financial assets, non-current (27.10)
Adjustments for other financial assets, current 4,527.50
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 5,085.40
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (727.50)
Adjustments for increase (decrease) in other non-current liabilities (7.00)
Adjustments for depreciation and amortisation expense 1,454.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 329.80
Adjustments for provisions, non-current 675.10
Adjustments for other financial liabilities, current (9,147.60)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (329.40)
Adjustments for dividend income 0.00
Adjustments for interest income 3,775.20
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 467.40
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (706.20)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 4,822.80
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (4,928.80)
Net cash flows from (used in) operations (2,284.10)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 437.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (2,721.10)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 7.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 47.40
Purchase of property, plant and equipment 1,646.60
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 3.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 1,05,825.60
Purchase of other long-term assets 1,65,246.20
Cash advances and loans made to other parties 624.70
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 5,212.30
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (56,442.20)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 81,600.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 468.10
Dividends paid 0.00
Interest paid 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (6,959.10)
Net cash flows from (used in) financing activities 74,172.80
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 15,009.50
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 15,009.50
Cash and cash equivalents cash flow statement at beginning of period 1,366.70
Cash and cash equivalents cash flow statement at end of period 16,376.20





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 S.R. Batliboi & Associates LLP Yes 31-08-2028


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 19-01-2026
Amount Raised 81,600.00
Report filed for Quarter ended 31-03-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Crisil Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review No comments
Comments of the auditors, if any No comments
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any


Signatory Details

Name of signatory Sridhar Muthukrishnan
Designation of person Company Secretary and Compliance Officer
Place Bengaluru
Date 20-05-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Amagi Media Labs Limited Amagi Corporation, USA Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 1,031.50 1,031.50
2 Amagi Media Labs Limited Amagi Media Labs Pte. Limited, Singapore Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 20.60 20.60
3 Amagi Media Labs Limited Amagi Media Private Ltd, United Kingdom Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 3,510.00 3,510.00
4 Amagi Media Labs Limited Amagi Canada Corporation Inc., USA Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 31.10 31.10
5 Amagi Media Labs Limited Amagi AI Private Limited, India Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 7.00 7.00
6 Amagi Corporation, USA Amagi Media Private Ltd, United Kingdom Subsidiary of Holding company Any other transaction Reimbursement 256.40 Approved by Audit Committee, where required 256.40 50.10 58.00
7 Amagi Media Private Ltd, United Kingdom Amagi Corporation, USA Subsidiary of Holding company Any other transaction Reimbursement 625.70 Approved by Audit Committee, where required 625.70 55.90 123.80
8 Amagi Corporation, USA Amagi Media UK Private Limited, United Kingdom Subsidiary of Holding company Any other transaction Reimbursement 20.60 Approved by Audit Committee, where required 20.60 3.80 2.10
9 Amagi Corporation, USA Argoid Analytics Inc., USA Subsidiary of Holding company Any other transaction Reimbursement 0.00 Approved by Audit Committee, where required 0.00 0.30 0.20
10 Amagi Corporation, USA Amagi Media Labs Pte. Limited, Singapore Subsidiary of Holding company Any other transaction Reimbursement 146.20 Approved by Audit Committee, where required 146.20 36.90 52.50
11 Amagi Media Labs Pte. Limited, Singapore Amagi Corporation, USA Subsidiary of Holding company Any other transaction Reimbursement 75.60 Approved by Audit Committee, where required 75.60 1.40 60.50
12 Amagi Media Private Ltd, United Kingdom Amagi Media Labs Pte. Limited, Singapore Subsidiary of Holding company Any other transaction Reimbursement 58.20 Approved by Audit Committee, where required 58.20 7.70 10.00
13 Amagi Media Labs Pte. Limited, Singapore Amagi Media UK Private Limited, United Kingdom Subsidiary of Holding company Interest received 24.50 Approved by Audit Committee, where required 24.50 12.80 0.00
14 Amagi Eastern Europe d.o.o. za usluge, Croatia Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 4.20 Approved by Audit Committee, where required 4.20 0.00 4.50
15 Amagi Media Labs Pte. Limited, Singapore Amagi Media UK Private Limited, United Kingdom Subsidiary of Holding company Loan 0.00 Approved by Audit Committee, where required 0.00 750.40 750.40
16 Amagi Media Labs Limited Baskar Subramanian Promoter, Managing Director and CEO Any other transaction Reimbursement 5.20 Approved by Audit Committee, where required 5.20 0.00 0.00
17 Amagi Media Labs Limited Srividhya S Promoter and Chief Technology Officer Any other transaction Reimbursement 2.00 Approved by Audit Committee, where required 2.00 0.00 0.00
18 Amagi Corporation, USA Arunachalam Srinivasan Karapattu Promoter and Director Any other transaction Reimbursement 10.50 Approved by Audit Committee, where required 10.50 0.00 10.10
19 Amagi Media Labs Limited Baskar Subramanian Promoter, Managing Director and CEO Remuneration 190.00 Approved by Audit Committee, where required 190.00 0.00 0.00
20 Amagi Media Labs Limited Srividhya S Promoter and Chief Technology Officer Remuneration 190.20 Approved by Audit Committee, where required 190.20 0.00 0.00
21 Amagi Corporation, USA Arunachalam Srinivasan Karapattu Promoter and Director Remuneration 363.30 Approved by Audit Committee, where required 363.30 0.00 0.00
22 Amagi Media Labs Limited Amagi Media Labs Pte. Limited, Singapore Subsidiary Sale of goods or services 1,307.80 Approved by Audit Committee, where required 1,307.80 487.00 52.30
23 Amagi Media Labs Limited Amagi Media Labs Pte. Limited, Singapore Subsidiary Any other transaction Reimbursement 90.20 Approved by Audit Committee, where required 90.20 0.00 31.30
24 Amagi Media Labs Limited Amagi Media Labs Pte. Limited, Singapore Subsidiary Any other transaction ESOP & SAR 57.90 Approved by Audit Committee, where required 57.90 0.00 6.80
25 Amagi Media Labs Pte. Limited, Singapore Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 69.30 Approved by Audit Committee, where required 69.30 47.50 0.00
26 Amagi Media Labs Limited Amagi Media Private Ltd, United Kingdom Subsidiary Sale of goods or services 10,219.80 Approved by Audit Committee, where required 10,219.80 0.00 0.00
27 Amagi Media Labs Limited Amagi Media Private Ltd, United Kingdom Subsidiary Any other transaction Reimbursement 53.70 Approved by Audit Committee, where required 53.70 0.00 1.90
28 Amagi Media Labs Limited Amagi Media Private Ltd, United Kingdom Subsidiary Any other transaction ESOP & SAR 78.20 Approved by Audit Committee, where required 78.20 0.00 65.60
29 Amagi Media Private Ltd, United Kingdom Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 94.00 Approved by Audit Committee, where required 94.00 444.80 7.40
30 Amagi Media Labs Limited Amagi Corporation, USA Subsidiary Sale of goods or services 36,336.10 Approved by Audit Committee, where required 36,336.10 15,610.80 11,084.50
31 Amagi Media Labs Limited Amagi Corporation, USA Subsidiary Any other transaction Reimbursement 510.30 Approved by Audit Committee, where required 510.30 460.40 200.10
32 Amagi Media Labs Limited Amagi Corporation, USA Subsidiary Any other transaction ESOP & SAR 1,234.40 Approved by Audit Committee, where required 1,234.40 121.40 554.40
33 Amagi Corporation, USA Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 4,082.30 Approved by Audit Committee, where required 4,082.30 1,781.40 286.00
34 Amagi Media Labs Limited Amagi Media UK Private Limited, United Kingdom Subsidiary Sale of goods or services 295.30 Approved by Audit Committee, where required 295.30 0.00 0.00
35 Amagi Media UK Private Limited, United Kingdom Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 22.40 Approved by Audit Committee, where required 22.40 1.90 1.40
36 Amagi Media Labs Limited Amagi Media UK Private Limited, United Kingdom Subsidiary Any other transaction Reimbursement (1.60) Approved by Audit Committee, where required (1.60) 0.00 0.00
37 Amagi Media Labs Limited Amagi Media UK Private Limited, United Kingdom Subsidiary Any other transaction ESOP & SAR 17.60 Approved by Audit Committee, where required 17.60 4.60 0.00
38 Amagi Media Labs Limited Amagi Media UK Private Limited, United Kingdom Subsidiary Purchase of goods or services 1,199.60 Approved by Audit Committee, where required 1,199.60 131.00 0.00
39 Amagi Media Labs Limited Amagi Eastern Europe d.o.o. za usluge, Croatia Subsidiary Any other transaction Reimbursement 0.00 Approved by Audit Committee, where required 0.00 240.40 99.80
40 Amagi Media Labs Limited Amagi Eastern Europe d.o.o. za usluge, Croatia Subsidiary Any other transaction ESOP & SAR 65.90 Approved by Audit Committee, where required 65.90 74.30 0.00
41 Amagi Media Labs Limited Amagi Eastern Europe d.o.o. za usluge, Croatia Subsidiary Purchase of goods or services 1,719.40 Approved by Audit Committee, where required 1,719.40 634.40 441.80
42 Amagi Media Labs Limited Argoid Analytics Inc., USA Subsidiary Sale of goods or services (17.50) Approved by Audit Committee, where required (17.50) 0.00 18.60
43 Amagi Media Labs Limited Argoid Analytics Inc., USA Subsidiary Any other transaction Reimbursement (0.30) Approved by Audit Committee, where required (0.30) 0.00 0.00
44 Argoid Analytics Inc., USA Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 0.00 Approved by Audit Committee, where required 0.00 1.10 0.00
45 Amagi Media Labs Limited Argroid Analytics Private Limited, India Subsidiary Any other transaction Rental Charges 0.10 Approved by Audit Committee, where required 0.10 0.00 0.10
46 Argroid Analytics Private Limited, India Amagi Media Labs Limited Holding Company Any other transaction Reimbursement 0.50 Approved by Audit Committee, where required 0.50 0.00 0.00
47 Amagi Media Labs Limited Amagi AI Private Limited, India Subsidiary Any other transaction Rental Charges 0.40 Approved by Audit Committee, where required 0.40 0.10 0.10
48 Amagi Media Labs Limited Amagi Corporation, USA Subsidiary Any other transaction Unearned Revenue 26.00 Approved by Audit Committee, where required 26.00 799.40 825.40
49 Amagi Corporation, USA Argoid Analytics Inc., USA Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 3,847.10 3,847.10
50 Amagi Media Private Ltd, United Kingdom Amagi Media UK Private Limited, United Kingdom Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 1,577.30 1,577.30
51 Amagi Media Private Ltd, United Kingdom Amagi Eastern Europe d.o.o. za usluge, Croatia Subsidiary Investment 0.00 Approved by Audit Committee, where required 0.00 1,080.00 1,080.00
Total value of transaction during the reporting period 59,434.40